Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel disease
Open Access
- 4 August 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1637159
Abstract
Background and aims: Artificial intelligence (AI) is rapidly gaining traction in gastroenterology, particularly in the management of inflammatory bowel disease (IBD). Given the complexity of IBD care, AI offers the potential to enhance diagnosis, monitoring, and treatment. This review aims to summarize recent developments in AI applications for IBD and identify key challenges and opportunities for future research and clinical implementation.Methods: A narrative literature review was conducted, incorporating recent studies utilizing AI —including machine learning (ML) and deep learning (DL) — across various aspects of IBD care.Results: AI has demonstrated utility in multiple domains of IBD management, including endoscopic disease activity assessment, histological evaluation, imaging interpretation, prediction of disease course, treatment response, and real-world data integration. Despite promising accuracy and utility, most models remain in early development stages and lack widespread clinical validation. Major barriers include data heterogeneity, limited generalizability, and regulatory uncertainties.Conclusion: AI has significant potential to revolutionize IBD care. Continued multidisciplinary collaboration, validation in diverse clinical settings, and integration into clinical workflows are critical for realizing its full impact.Keywords
This publication has 126 references indexed in Scilit:
- An artificial intelligence‐driven scoring system to measure histological disease activity in ulcerative colitisUnited European Gastroenterology Journal, 2024
- Inflammatory bowel disease biomarkersMedicinal Research Reviews, 2022
- Machine learning gene expression predicting model for ustekinumab response in patients with Crohn's diseaseImmunity, Inflammation and Disease, 2021
- Prediction of outcome of treatment of acute severe ulcerative colitis using principal component analysis and artificial intelligenceJGH Open, 2020
- Comparing deep belief networks with support vector machines for classifying gene expression data from complex disordersFEBS Open Bio, 2019
- Performance of a Deep Learning Model vs Human Reviewers in Grading Endoscopic Disease Severity of Patients With Ulcerative ColitisJAMA Network Open, 2019
- Development and Validation of Machine Learning Models in Prediction of Remission in Patients With Moderate to Severe Crohn DiseaseJAMA Network Open, 2019
- Curved planar reformatting and convolutional neural network‐based segmentation of the small bowel for visualization and quantitative assessment of pediatric Crohn's disease from MRIJournal of Magnetic Resonance Imaging, 2018
- Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challengesHuman Mutation, 2017
- CAGI4 Crohn's exome challenge: Marker SNP versus exome variant models for assigning risk of Crohn diseaseHuman Mutation, 2017